middle.news
Orthocell’s Remplir finds early traction in complex prostate surgery
9:11am on Tuesday 13th of October, 2026 AEDT
•
Healthcare
Read Story
Orthocell’s Remplir finds early traction in complex prostate surgery
9:11am on Tuesday 13th of October, 2026 AEDT
Key Points
Three of five patients were pad-free by six months
Three of four patients with pre-surgery erectile function regained some function with treatment
No Remplir-related complications or significant added operating time reported
More than 300 Australian prostatectomy procedures have now used Remplir
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE